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Abstract
Background:  Genetic components controlling for echocardiographically determined left
ventricular (LV) mass are still unclear in the Chinese population.
Methods: We conducted a family study from the Chin-San community, Taiwan, and a total of 368
families, 1145 subjects, were recruited to undergo echocardiography to measure LV mass.
Commingling analysis, familial correlation, and complex segregation analysis were applied to detect
component distributions and the mode of inheritance.
Results:  The two-component distribution model was the best-fitting model to describe the
distribution of LV mass. The highest familial correlation coefficients were mother-son (0.379, P <
.0001) and father-son (0.356, P < .0001). Genetic heritability (h2) of LV mass was estimated as 0.268
± 0.061 (P < .0001); it decreased to 0.153 ± 0.052 (P = .0009) after systolic blood pressure
adjustment. Major gene effects with polygenic components were the best-fitting model to explain
the inheritance mode of LV mass. The estimated allele frequency of the gene was 0.089.
Conclusion: There were significant familial correlations, heritability and a major gene effect on LV
mass in the population-based families.
Background
Left ventricular (LV) hypertrophy profoundly affects mor-
bidity and mortality from cardiovascular diseases, includ-
ing myocardial infarction, congestive heart failure, and
stroke [1,2]. Therefore, it is important to measure LV mass
and manage LV hypertrophy among the hypertensive
population in clinical practice [3]. The noninvasive imag-
ing methods of echocardiography have greatly expanded
our capability in evaluating increased LV mass, and have
thus enhanced our understanding of the natural history of
LV hypertrophy [4-6]. Blood pressure and volume over-
load are recognized as a strong determinant of LV hyper-
trophy [7]; however, interindividual variations in LV mass
can be explained, only to a limited extent, by hemody-
namic load [8]. Moreover, LV hypertrophy may occur in
the absence of hypertension [9]. Genetic components
have been considered as important factors for LV mass,
and twin studies have shown that heritability accounts for
up to 20–70% [10-13].
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The family member study design is a useful tool for inves-
tigating genetic and environmental components of com-
plex traits [14]. Significant heritability and evidence of
strong familial aggregation in LV mass have been reported
in different populations, such as in Caucasian [10,13,15-
18], African Americans [17,19], American Indians [12]
and Caribbean Hispanic families [20]. But data based on
Chinese are not available. Furthermore, investigation on
the mode of inheritance by segregation analysis among
families can provide parametric estimates for linkage
analyses [21]. Even though some major susceptibility
genes have already been identified, segregation analysis
can provide further evidence for major gene effects in the
trait [22]. Previous segregation study showed the mode of
inheritance of LV mass was compatible to polygenic
model [13], but the study did not prove major gene effects
controlling LV mass. Segregation analysis can investigate
if the major gene effects exist, besides the polygenic back-
ground effects, and help to facilitate the further genomic
study.
The study of young families from one community could
provide a feasible way to investigate genetic components
among the general population, because hypertension
complications are comparatively rare and the environ-
mental factors are more homogeneous than hospital-
based subjects. The researchers in the Tecumseh Offspring
Study showed that among the young population (mean
17 years old), parental LV mass explained a meaningful
small percentage for adolescent offspring LV mass vari-
ance[23]. The community-based family study was to
investigate the mode of inheritance of LV mass in the Tai-
wanese population.
Methods
Subjects
This family study was part of the Chin-Shan Community
Cardiovascular Cohort Study, a prospective cohort study
beginning in 1990 [24,25]. The family study arm started
in 1997 and was designed to recruit adolescent probands
from students in the only junior high school in the com-
munity. The proposal was approved by the Institutional
Review Board of National Taiwan University Hospital and
oral informed consent was obtained in each participant.
At first, a total of 1063 students (with a response rate of
94.6%) agreed to participate in a general health check-up
after informed consent was obtained. They underwent
examinations for anthropometric measures, blood pres-
sure, lipid profiles and echocardiographic measures. The
selected youths were stratified into two groups on the
basis of seven measures, including total cholesterol, trig-
lyceride, low density lipoprotein (LDL) cholesterol, body
mass index, systolic pressure, diastolic pressure, and high
density lipoprotein (HDL) cholesterol. There were 368
students selected for this study. All the students with val-
ues below the 10th percentile for HDL cholesterol and
above the 90th percentile (for all students in this study)
for any of the other six measures, were ascertained as high-
risk probands (n = 171). The control young probands (n
= 197) were randomly sampling from other young stu-
dents. After obtaining informed consent from probands'
family members, the same measures were performed for
each family member.
Because the original stratification was not based exclu-
sively on LV mass and the results of segregation analysis
for the families were similar, the results of all families
together with correction for ascertainment on proband's
status were reported in this study. The ascertainment strat-
egy is to select probands in upper 90th percentiles of the
risk factor distribution, and this strategy can substantially
increase the power over random sampling. We used the
proband high risk status as a surrogate strategy, which
could identify individuals in high extreme LV mass distri-
bution in the regressive model.
Echocardiographic examination
Echocardiographic measures have been described in
detail previously [4]. Four cardiologists performed and
read the measurements. All subjects were asked to lie in
the left lateral decubitus position to assure standardized
measurement. We recorded the real-time image in video
tapes simultaneously and calculated the measures in con-
secutive beats. We checked the agreement and reliability
among these 4 cardiologists as follows. A sub-sample of
15 participants was selected to receive echocardiography
by all four physicians to estimate the inter-observer varia-
bility of measurement parameters. The intraclass correla-
tion reliability was calculated by a simple replication one-
way analysis of variance test [26]. The values of interrater
correlation coefficient reliability of LV mass were 0.80,
indicating good agreement.
The LV mass was calculated by the Penn convention [27],
and normalized LV mass values were calculated by one
allometric value of height of power, 2.7, as suggested by
de Simone et al [28].
Statistical analysis
LV mass and related characteristics of the study partici-
pants were specified by proband, sibling and parent sta-
tus. Mean, standard deviation, skewness and kurtosis were
presented to show the distribution of related traits. The
residual LV mass from the multiple linear regression
model, after adjusting for age, gender, body mass index,
smoking, and alcohol drinking status, plus sample mean,
were used for further genetic analysis.BMC Cardiovascular Disorders 2006, 6:37 http://www.biomedcentral.com/1471-2261/6/37
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Genetic analysis
We used commingling analysis on LV mass values to test
whether the data were best described by one, two, or three
more Normal distributions by ADMIX program [29]. The
parameters for each component's mean, variance and pro-
portion were estimated by the maximum likelihood
method. The best-fitted commingling distribution model
was defined by comparing the likelihood ratio test statis-
tics among different nested models.
The intra-familial correlation coefficients of LV mass trait
were measured in different pairs, including spouse, par-
ent-offspring, and siblings, by FCOR program in S.A.G.E.
[30]. We tested if the correlation coefficients of parent-off-
spring pairs were statistically different from zero by the
Fisher's z test [31]. Heritability estimate of LV mass in the
families was estimated by the variance component model,
which was implemented in the SOLAR software [32].
Complex segregation analysis
Segregation analysis of adjusted LV mass was conducted
using regressive models as implemented in the REGC pro-
gram in S.A.G.E. [30]. These models assume that the vari-
ation of LV mass among family members is the result of a
major gene effect, with residual variation reflecting both
familial correlations and individual variation. The pres-
ence of a major gene is assessed by allowing two factors or
alleles (A and B) at a single locus, resulting in three 'ousi-
otypes' (AA, AB, BB) in individuals. The means of LV mass
for each ousiotype is denoted μAA, μAB, μBB, with one com-
mon variance of σ2. The frequencies of allele A and B are
denoted qA and (1- qA), respectively. The distribution of
types in the population is assumed to be in Hardy-Wein-
berg equilibrium. Individuals of each type are assumed to
transmit allele A to their offspring with transmission
probabilities τAA, τAB and τBB, respectively. Residual famil-
ial resemblance unable to be explained by this major
locus is modeled by familial correlations. The correlation
between spouses, parents and offspring, mother and off-
spring, father and offspring, and between siblings are
denoted ρMF, ρPO, ρMO, ρFO, and ρSS, respectively. For this
study, we adopted class D regressive models, in which
residual sib-sib correlations are equal among all sibs of
common parentage and can be due to any cause. If ρPO is
held equal to ρSS, these models have been shown to be
mathematically and numerically equivalent to the con-
ventional mixed model of inheritance in nuclear families
[33].
The analyses started with fitting a general model, in which
all parameters were allowed to be estimated. Then we
compared the general model with various submodels, in
which certain parameters were restricted to specific values.
Under a Mendelian model, the transmission probabili-
ties, i.e., τAA, τAB and τBB, were held equal to Mendelian
expectations of 1, 0.5, and 0. A nontransmitted environ-
mental effect model predicted that the probability of an
individual having one ousiotype or another was inde-
pendent of both the person's generation and the ousio-
types of his/her parents. For the environmental model in
this study, each of the transmission probabilities was
taken to be equal to the factor frequency, i.e., τAA = τAB =
τBB = qA. Both the Mendelian and environmental models
can allow for residual familial correlations. A pure poly-
genic model assumed no major gene effect, so gene fre-
quency and transmission probabilities were all fixed to
one. The fit of hierarchical models was compared with the
likelihood ratio test, calculated as -2 of the difference
between the ln likelihood of the models being compared.
The likelihood ratio value follows a chi-square distribu-
tion, with degrees of freedom equal to the difference
between the models in the number of parameters esti-
mated. Among nonhierarchical models, the most parsi-
monious model is that with the lowest values of Akaike's
information criterion (AIC = -2 ln likelihood +2 [number
of estimated parameters]) [34].
We used the adjusted LV mass values without a logarithm
transformation for the segregation analysis since a nor-
malizing transformation of a skewed trait would decrease
the power to detect a major gene effect when one exists
[35]. We fitted the environmental model to detect possi-
ble environmental effects. If such a model was rejected,
the major gene effects were not caused by the skewness of
the LV mass levels [36].
Results
Description of study participants
The characteristics of LV mass and related factors among
probands, siblings, and their parents are presented in
Table 1. The parents had higher blood pressure, LV mass,
and smoking and drinking rates than the probands and
siblings. In addition, the parents had larger standard devi-
ations in BMI, blood pressure and LV mass measures than
their offspring. The values of skewness and kurtosis
showed that LV mass measures were nearly zero, indicat-
ing nearly normal distribution in LV mass. The proportion
of the variation in LV mass in this sample explained by
gender, age, body mass index, smoking and drinking sta-
tus was 51%.
Commingling analysis results
Commingling analysis showed that a 2-component,
rather than a single-component distribution, was the best-
fit model for LV mass variations. The component means,
variances, and proportions for the 2-component distribu-
tion model were (-0.168, 1.029), (0.661, 1.837) and
(85.9%, 14.1%), respectively. The χ2 test for comparing
the 2-component with the 3-component distribution was
not significant (χ2 = 5.45, df = 3, p = 0.142), indicatingBMC Cardiovascular Disorders 2006, 6:37 http://www.biomedcentral.com/1471-2261/6/37
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that the 2-component distribution was the best-fit model.
It implied that there were major gene effects. The observed
and expected distributions from commingling results
were plotted in Figure 1. This shows close approximation
of expected to observed distribution.
Familial correlation and genetic heritability estimates
Significant spouse, parent-offspring and sibling coeffi-
cients were found (Table 2), and the highest values were
mother-son (0.379, P < .0001) and father-son (0.356, P <
.0001). There were significant spouse and sibling correla-
tion coefficients (0.254, 0.169, both P < .0001). Genetic
heritability (h2) of LV mass was estimated as 0.268 ±
0.061 (P < .0001), indicating significant genetic compo-
nents controlling LV mass trait. After adjusting for systolic
pressure, heritability decreased to 0.153 ± 0.052 (P  =
.0009).
Complex segregation analysis result
We used the complex segregation analysis to detect if
major gene effects exist to control LV mass trait. We con-
structed several models, including sporadic, polygenic,
environmental and major gene (Mendel) models to esti-
mate the parameters such as gene frequency, transmis-
sion, penetrance and correlations from family data (Table
3). Compared with a general unrestricted model, the chi-
square and corresponding P values were presented. We
found that the pure major gene effects model and mixed
codominant model were similar with the full model (P
values 0.370 and 0.214, respectively). The pure major
gene effects model had the smallest AIC value and was
considered as the best-fit model to explain the mode of
inheritance of LV mass. Under this major gene effects
model, we found that the gene, which controlled high LV
mass values, had an allele frequency of 0.098, and the
three means of LV mass were 64.4, 45.7 and 33.9 gm/m.
Polygenic effects, presented by familial correlation, were
Table 2: Familial correlation coefficients and significant levels for 
testing the null hypothesis among the various familial pairs in the 
studied family members.
Pairs Numbers Coefficients P value
Spouse 162 0.254 0.001
Parent-offspring 889 0.294 0.000
Sibling 427 0.169 0.000
Grandparent-child 287 0.179 0.002
Mother-daughter 220 0.254 0.000
Mother-son 252 0.379 0.000
Father-daughter 205 0.084 0.231
Father-son 212 0.356 0.000
Sister-sister 131 0.136 0.121
Sister-brother 209 0.162 0.019
Brother-brother 87 0.208 0.053
Observed (histogram) and expected (linear) distributions of  adjusted left ventricular mass in the study subjects Figure 1
Observed (histogram) and expected (linear) distributions of 
adjusted left ventricular mass in the study subjects. Two thin 
lines were plotted from 2-component Normal distributions 
with means as (-0.168, 1.029) and variance as (0.661, 1.837), 
respectively. The thick line was the summation of two thin 
lines.
Table 1: Basic characteristics of participants in the study, specified by generations (n = 1,145)
Probands (N = 368) Siblings (N = 333) Parents (N = 444)
Mean SD Skewness Kurtosis Mean SD Skewness Kurtosis Mean SD Skewness Kurtosis
Age (years) 16.45 0.97 0.33 0.34 17.83 3.43 0.59 1.05 43.65 5.74 1.35 4.65
BMI (kg/m2) 20.63 3.87 1.13 1.24 20.08 3.13 1.31 4.26 24.23 3.91 1.03 4.40
SBP (mmHg) 108.86 13.02 0.34 -0.34 111.65 12.90 0.36 0.27 119.13 15.12 0.82 1.28
DBP (mmHg) 67.79 9.33 -0.05 -0.75 70.66 10.36 0.18 0.51 78.48 11.46 0.70 0.68
LV mass (gm) 117.02 39.99 1.00 1.06 111.10 38.26 0.91 0.87 150.08 48.65 0.62 0.21
LV mass index (gm/m2.7) 31.93 9.41 1.02 1.88 30.39 8.80 0.87 1.49 41.16 11.59 0.47 -0.11
Smoking 1 (0.3%) 35 (10.5%) 159 (35.8%)
Alcohol drinking 1 (0.3%) 25 (7.5%) 173 (39.0%)
Abbreviated: BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, LV: left ventricularB
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Table 3: Parameter estimates from segregation analysis of residual LV mass values: Class D regressive models, conditional on proband phenotypes
Model Pure familial correlation, i.e. 
polygenic
Pure major gene (Mendel) Mendel + familial correlation 
(mixed codominant)
A Dominant, μAB = μAA A Recessive, i.e. B 
Dominant, μAB = μBB
Unrestricted, general
Parameter S.E. Parameter S.E. Parameter S.E. Parameter S.E. Parameter S.E. Parameter S.E.
qA [1] 0.098 0.028 0.093 0.030 0.040 0.020 0.000 0.142 0.109 0.024
τAA - [1] [1] [1] [1] 1.000 0.000
τAB - [0.5] [0.5] [1] [1] 0.249 0.100
τBB - [0] [0] [0] [0] 0.034 0.030
μAA 36.0 0.5 64.4 4.3 65.1 4.5 51.4 2.8 40.9 8.2 62.7 3.4
μAB = μAA 45.6 1.8 45.7 1.9 51.4 2.8 36.0 0.5 46.1 1.4
μBB = μAA 33.7 0.5 33.9 0.6 34.9 0.6 36.0 0.5 33.5 0.6
σ2 80.6 4.6 52.4 4.2 53.5 4.7 61.8 5.5 80.6 4.6 47.1 4.9
ρMF 0.199 0.072 0.327 0.093 0.315 0.091 0.246 0.079 0.199 0.072 0.334 0.098
ρMO 0.196 0.050 [0] 0.058 0.070 0.130 0.067 0.196 0.050 0.076 0.079
ρFO 0.093 0.059 [0] -0.070 0.069 -0.025 0.064 0.093 0.059 -0.051 0.076
ρSS 0.118 0.055 [0] 0.000 0.000 0.037 0.069 0.118 0.055 0.017 0.065
#  o f 66988 1 2
parameters
-2ln(L) 4721.80 4684.40 4682.38 4688.22 4721.80 4677.90
AIC 4733.8 4696.4 4700.38 4704.22 4737.8 4701.9
χ2 43.9 6.5 4.48 10.32 43.9
P 0.000 0.370 0.214 0.035 0.000 Baseline
Abbreviation: qA, allele frequency; τAA, τAB, τBB, transmission probability; μAA, μAB, μBB, genotype means; σ2, variance; ρMF, ρMO, ρFO, ρSS, correlation coefficients among spouse, mother-offspring, father-
ffspring and sibling pairs; #, number of parameters; ln(L), logarithm of likelihood; AIC, Akaike information criteria; P, p-value by compared with the unrestricted general model.BMC Cardiovascular Disorders 2006, 6:37 http://www.biomedcentral.com/1471-2261/6/37
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also demonstrated and there was significant spouse corre-
lation up to 0.327.
Discussion
Significant heritability and familial correlations of LV
mass were proven in this study, based on a large number
of adolescent proband families. We also demonstrated
that the inheritance mode of LV mass was compatible
with major genes effects among the Chinese population.
This study had two scientific contributions. First, there is
considerable homogeneity in this study population. Most
of the subjects live in the same community; hence their
social and living environments tended to be more similar
than those in different communities. Also, the characteris-
tics of study subjects can avoid the potential bias of
recruitment from a hospital setting. Second, the results are
particularly relevant for a population at low risk for
atherosclerosis, since the probands were systematically
selected from young adolescents in the community, in
which the complication of hypertension and LV hypertro-
phy were not prevalent in the study population.
There are many reports on left ventricular mass heritabil-
ity with estimates from different populations (Table 4).
Most studies showed significant heritability and sibling
correlations, especially among African Americans. Our
study results were compatible with Caucasian population
studies [13,15,17]. The high heritability estimates in Afri-
can Americans might be due to ascertainment from hyper-
tensive hyperlipidemic proband siblings [19]. Caribbean
Hispanics population had high estimate [20]. Variation
on heritability estimates of LV mass might be explained by
different ethnicity. Also, the different expression of a com-
plex polygenic trait in relation to unmeasured factors
might be involved.
The heritability decreased after adjusting for blood pres-
sure. It implied possible pleiotrophic effects of genes on
controlling blood pressure and LV mass. Hemodynamic
load, such as stroke volume, has an influence on LV mass
among young adults and adolescents, and this impact is
more important than body size. However, high propor-
tions of LV mass variations still remain unexplained [8].
Genetic components played important role in residual LV
mass variations. We ascertained young proband families,
where hypertension complications are comparatively rare,
and from one community population, where environ-
mental factors are rather homogeneous for genetic stud-
ies. Our study subjects were rather young, and our results
showed results similar to the Tecumseh offspring study
[23].
We found the highest correlations were in parent-son
pairs, which indicated male offspring had influential
effects from parents. Our estimate of sibling correlation
was as the same as Framingham sibling pairs (0.16), while
the estimates of parent-offspring and spouse correlations
(0.29 and 0.25, respectively) were much higher than those
in Framingham pairs (0.15 in parent-offspring, 0.05 in
spouse) [15]. For intra-familial resemblance, greater
father-offspring correlations were observed among the
British Caucasian population, much higher than mother-
child correlations [17]. Our study also showed sex-specific
patterns of familial correlations; the highest was the par-
ent-son pairs (0.36–0.38) and the lowest was the father-
daughter (0.08). Different parent-of-origin effects on off-
spring LV mass was reported in European families [37].
The mother-offspring correlation coefficient was signifi-
cantly higher than father-offspring correlation among the
European population. The discrepancy implies the impor-
tance of ethnic difference on parental factors on offspring
traits. Also, high spouse correlation implies that the com-
mon household effects were important for controlling LV
mass. Lifestyle habits, such as salt intake and physical
activity, might be also familial aggregation and may thus
explain the high correlation between spouse pairs.
There were several studies on genomic profiles for LV
mass. For example, a cross-breeding hypertensive rat
model demonstrated two loci with high LOD scores
[38,39]. There were many reports on candidate genes such
as G-protein beta-3, aldosterone synthase, and beta-1
adrenoceptor genes associated with LV mass [18,40]. Our
study results can provide further genomic research on LV
mass.
Study limitations
The limitations of our study were as follows. Firstly, only
mathematical modeling methods such as commingling
and segregation analyses were investigated and no candi-
date gene markers were investigated. Although we postu-
lated one major gene with allele frequency around 0.1
controlling LV mass and 2-component commingling pat-
terns, we did not shed light on which genes most likely
involved. Secondly, epistasis among genes or gene-envi-
ronmental interaction cannot be explored in this study.
Incorporation with environmental factors can elucidate
the possible roles of risk factors and interaction effects.
Conclusion
We showed that there were significant parent-son correla-
tion coefficients, genetic heritability and major gene
effects controlling LV mass among ethnic Chinese in Tai-
wan. Candidate gene markers could be used to investigate
the association and linkage with LV mass.
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Table 4: Summary of heritability estimates of left ventricular mass trait
Author, year Study design Study population 
origins
Numbers of families/
subjects
Adjusted covariate Heritability estimate 
(h2)
Comments
Post et al. 1997 15 Relative pairs Caucasians, Framingham 
families, no systemic 
diseases
2624 subjects Age, height, weight, systolic 
blood pressure
0.24–0.32 Limit in subjects without 
systemic diseases nor 
medication history
Garner et al. 2000 13 Nuclear families White, European families 149/624 weight 0.28 Children population
Kotchen et al. 2000 19 Sibling African American, 
hypertensive, 
hyperlipidemia
68 sibpairs Age, gender 0.65–0.72 FCOR and ASSOC in SAGE 
program to perform the 
analysis
Arnett et al. 2001 16 Sibling African Americans & white 
hypertensive
1664 siblings Age, gender, systolic blood 
pressure, obesity
Sibling correlations 0.29–
0.44 in African American, 
0.04–0.12 in white
High sibling correlation in 
African Americans
Palatini et al. 2001 23 Nuclear families Tecumseh Offspring Study 251 offspring and 290 
parents
Age, gender, body height 
systolic blood pressure, 
insulin, urinary sodium 
excretion,
No estimate of h2, parental 
LV mass explained 7.6% of 
total variance of offspring 
LV mass
Multiple linear regression 
models Young offspring 
(mean 17 years old)
Mayosi et al. 2002 17 Extended families British Caucasians, 
hypertensive probands 
from hospital or clinics
229/955 Age, systolic blood 
pressure, weight, height, 
WHR, diabetes
0.23–0.29 Ascertainment correction: 
yes
Swan et al. 2003 18 Twins Caucasians, Population-
based
55 pairs MZ vs. 55 pairs DZ Age, gender, blood 
pressure, weight
0.53–0.69
Bella et al. 2004 12 Relative pairs, mostly sibpairs American Indian families, 
different geographic 
location
455/1373, 1305 relative 
pairs, 1077 sibpairs
Age, gender, centers, 
weight, height, systolic 
blood pressure, heart rate, 
medication, diabetes
0.17(multiple adjusted) -
0.27 (first three variates 
adjusted)
No significant heritability in 
Arizona Indians
Juo et al. 2005 20 Extended families Caribbean Hispanics 84/623 Age, gender, weight 0.51 Adding systolic blood 
pressure, diabetes, 
medication did not affect 
the estimate
This report Nuclear families Ethnic Chinese, young 
probands, community-
based
368/1145 Age, gender, body mass 
index, blood pressure
0.15 (multiple adjusted) -
0.27 (first 3 variates 
adjusted)BMC Cardiovascular Disorders 2006, 6:37 http://www.biomedcentral.com/1471-2261/6/37
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